BioNTech co-founders Ugur Sahin and Özlem Türeci are set to leave the company to head the new venture.
BioNTech SE (BNTX) on Tuesday revealed plans to launch a separate biotechnology venture dedicated to advancing next-generation messenger RNA technologies, with the initiative to be led by its co-founders Ugur Sahin and Prof. Özlem Türeci, who are set to leave the company to head the new venture.
Add Asianet Newsable as a Preferred Source
The new entity will operate independently with its own financial structure, research agenda, and operational framework while collaborating with BioNTech in specific areas of development.
Following the announcement, BioNTech stock tumbled nearly 17% in Tuesday’s premarket.
Get updates to this developing story directly on Stocktwits.<
